GLP1R and type 2 diabetes mellitus: Based on the available literature, our objective was to provide an overview and compare GLP-1 RAs and SGLT inhibitors regarding mechanisms of action, potential adverse effects, and ability to modify or prevent cardiovascular comorbidities associated with T2DM.